A new phase of strategic investment
Alexis Jubert, Chairman of Seiven, has announced that it is acquiring a majority stake of 40 %, after buying out the shares of its initial investors. This move marks a strong desire to stabilise the group's governance and embark on a new stage of expansion. Seiven, which also owns Isofroid, has eight brands covering the entire post-mortem process.
Objectif Europe: focus on external growth
Seiven's ambition is to become a European reference by structuring its development around targeted acquisitions. Germany, Belgium, the Netherlands and the UK have been identified as high-potential markets. The challenge is to pool industrial expertise while maintaining the local roots needed to support families.
